Prestige Consumer Healthcare (NYSE:PBH) Hits New 12-Month Low - What's Next?

Key Points

• Prestige Consumer Healthcare hit a new 52-week low, trading as low as $42.30 on Friday, down from a prior close of $44.32.
• Analyst sentiment is mixed but averages to a Hold rating; the consensus price target is $67.67. Zacks Research cut its rating from Strong Buy to Hold, while Weiss Ratings maintained a Sell rating.
• The latest quarterly results beat expectations: earnings were $1.13 per share versus $1.07 expected, and revenue reached $336.31 million, up 22.7% year over year.

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) reached a new 52-week low during trading on Friday. The stock traded as low as $42.30 and last traded at $42.9660, with a volume of 37,944 shares trading hands. The stock had previously closed at $44.32.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the stock. Zacks Research lowered shares of Prestige Consumer Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Thursday, October 29th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 22nd. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $67.67.

Prestige Consumer Healthcare Trading Down 2.8%

The business has a 50 day moving average of $48.34 and a two-hundred day moving average of $53.88. The firm has a market cap of $2.04 billion, a P/E ratio of 12.06, a PEG ratio of 1.67 and a beta of 0.30. The company has a current ratio of 3.23, a quick ratio of 1.99 and a debt-to-equity ratio of 1.06.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $1.13 EPS for the quarter, topping analysts' consensus estimates of $1.07 by $0.06. The firm had revenue of $336.31 million during the quarter, compared to analysts' expectations of $329.14 million. Prestige Consumer Healthcare had a net margin of 15.57% and a return on equity of 11.39%. The company's revenue for the quarter was up 22.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.07 earnings per share. Analysts predict that Prestige Consumer Healthcare Inc. will post 4.56 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Versant Capital Management Inc increased its position in Prestige Consumer Healthcare by 47.9% during the 2nd quarter. Versant Capital Management Inc now owns 726 shares of the company's stock worth $34,000 after buying an additional 235 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of Prestige Consumer Healthcare by 19.4% in the first quarter. EverSource Wealth Advisors LLC now owns 1,531 shares of the company's stock valued at $91,000 after acquiring an additional 249 shares during the period. Illinois Municipal Retirement Fund boosted its position in shares of Prestige Consumer Healthcare by 1.1% in the first quarter. Illinois Municipal Retirement Fund now owns 26,114 shares of the company's stock valued at $1,548,000 after acquiring an additional 281 shares during the period. Corient Private Wealth LP boosted its position in shares of Prestige Consumer Healthcare by 1.3% in the second quarter. Corient Private Wealth LP now owns 25,398 shares of the company's stock valued at $1,201,000 after acquiring an additional 331 shares during the period. Finally, Hohimer Wealth Management LLC grew its stake in shares of Prestige Consumer Healthcare by 8.2% in the third quarter. Hohimer Wealth Management LLC now owns 4,623 shares of the company's stock valued at $212,000 after acquiring an additional 349 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc NYSE: PBH is a consumer healthcare company that develops, acquires, markets and distributes over-the-counter health and wellness products. Its portfolio is focused on established brands designed to address everyday healthcare needs, including digestive health, eye and ear care, oral care, pain relief, cold and allergy symptoms, feminine care and dermatological conditions.

The company's brands include Dramamine and Bonine for motion-sickness relief; BC and Goody's for pain relief; Clear Eyes and Murine for eye and ear care; Chloraseptic for sore-throat relief; Compound W for wart removal; Fleet for gastrointestinal health; and Summer's Eve for feminine care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.